NEW YORK — Sesame, a direct-pay healthcare marketplace, announced it has raised an additional $24 million, including new investments from Giant Ventures, Industry Ventures and Coefficient Capital. Existing investors General Catalyst, Entree Capital, and Atreides Management have also contributed additional funds to help Sesame scale. The latest funding brings Sesame’s total capital raised to just under $50 million since its founding in 2019.
“Only radical simplicity will fix a complex system like healthcare,” said Sesame CEO and Co-founder David Goldhill. “Right now, the healthcare industry works really well if you’re an insurance company or a hospital. But not if you’re a patient or a doctor. We’re changing that every single time a patient finds, books, and pays for care directly on Sesame.”
Sesame will use the new funding to strengthen its dynamic, full-scope marketplace and expand its nationwide telehealth offerings and in-person care. This latest funding follows Sesame’s successful expansion into national telehealth coverage to complement its comprehensive in-person offerings. With over 1,000 providers treating patients across all 50 states, Sesame’s business has grown 25x in the past year. Sesame is launching prescription medication delivery this month, giving cash-pay patients convenient access to affordable medication.
Cameron McLain, Managing Partner of Giant Ventures, said: “What the Sesame team has built in the last year has the promise to completely transform the direct-pay healthcare space. US healthcare has historically been defined by exclusivity and complexity. Sesame is our best shot at changing that as they build a healthcare ecosystem defined by quality, inclusivity, and broad accessibility for all.”
